Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 1Gastrointestinal 1

Conditions

Pulmonary Aspergillosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycoses 1Leukemia, Myelomonocytic, Acute 1Leukemia 1Invasive Pulmonary Aspergillosis 1Invasive Fungal Infections 1Aspergillosis 1

Interventions

Cyclophosphamide 886Rituximab 864Vincristine 382Etoposide 381fludarabine 342Cytarabine 341Doxorubicin 340fludarabine phosphate 319Methotrexate 310Dexamethasone 283Prednisone 281Lenalidomide 245Filgrastim 228Melphalan 200Peripheral Blood Stem Cell Transplantation 184Radiotherapy 175Whole-Body Irradiation 172Busulfan 165Mycophenolic Acid 161venetoclax 158Bendamustine Hydrochloride 158Granulocyte Colony-Stimulating Factor 151Tacrolimus 145ibrutinib 144Bortezomib 138obinutuzumab 125Gemcitabine 113Cyclosporine 110Antilymphocyte Serum 103Carmustine 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Amphotericin B × Lymphoid × Clear all
NCT01615809 2018-03-29

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia

Fundació Sant Joan de Déu

Phase 2 Completed
32 enrolled 6 charts
LymphoidOther hematologic neoplasm

Invasive Fungal Infections, Aspergillosis, Leukemia, Mycoses, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pulmonary Aspergillosis, Invasive Pulmonary Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡